On Tuesday, Gossamer Bio Inc (NASDAQ: GOSS) opened higher 7.20% from the last session, before settling in for the closing price of $2.36. Price fluctuations for GOSS have ranged from $0.66 to $2.44 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 40.29% annually for the last half of the decade. Company’s average yearly earnings per share was noted -165.97% at the time writing. With a float of $182.70 million, this company’s outstanding shares have now reached $227.32 million.
Gossamer Bio Inc (GOSS) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Gossamer Bio Inc is 19.65%, while institutional ownership is 61.50%. The most recent insider transaction that took place on Aug 19 ’25, was worth 50,016. In this transaction Director of this company bought 26,050 shares at a rate of $1.92, taking the stock ownership to the 58,050 shares.
Gossamer Bio Inc (GOSS) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.14 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.14) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -165.97% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.33% during the next five years compared to 40.29% growth over the previous five years of trading.
Gossamer Bio Inc (NASDAQ: GOSS) Trading Performance Indicators
Check out the current performance indicators for Gossamer Bio Inc (GOSS). In the past quarter, the stock posted a quick ratio of 4.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.61, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.49 in one year’s time.
Technical Analysis of Gossamer Bio Inc (GOSS)
Let’s dig in a bit further. During the last 5-days, its volume was 3.45 million. That was better than the volume of 1.98 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 93.09%.
During the past 100 days, Gossamer Bio Inc’s (GOSS) raw stochastic average was set at 97.79%, which indicates a significant increase from 95.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.15 in the past 14 days, which was higher than the 0.12 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.70, while its 200-day Moving Average is $1.20. However, in the short run, Gossamer Bio Inc’s stock first resistance to watch stands at $2.61. Second resistance stands at $2.69. The third major resistance level sits at $2.80. If the price goes on to break the first support level at $2.41, it is likely to go to the next support level at $2.30. The third support level lies at $2.22 if the price breaches the second support level.
Gossamer Bio Inc (NASDAQ: GOSS) Key Stats
There are currently 227,381K shares outstanding in the company with a market cap of 575.27 million. Presently, the company’s annual sales total 114,700 K according to its annual income of -56,530 K. Last quarter, the company’s sales amounted to 11,490 K and its income totaled -38,270 K.
